Pharming convenes Extraordinary General Meeting of shareholders
Pharming Group N.V. announces it will hold an Extraordinary General Meeting (EGM) of Shareholders on Friday 11 December 2020 at 14:00 CET.
Further to Pharming’s announcement on 20 May 2020, the EGM will address the appointment of two new Supervisory Directors, Ms. Barbara Yanni and Dr. Mark Pykett, as well as the Company’s new remuneration policy and related remuneration proposals for the company’s executive and non-executive board members.
In addition, further to the Company announcing today, that it has initiated the process for a secondary listing in the US on Nasdaq, the EGM will also address a proposal to amend the Company’s articles of association for the implementation of a one-tier Board structure in anticipation of the launch of the Level 2 ADR Programme and the associated Nasdaq listing. The Company has not made any decisions regarding either the timing, or the terms of the Level 2 ADR programme and there can be no certainty that the Nasdaq listing in the US will take place.
In accordance with the precautionary measures invoked by the Dutch government due to the extraordinary circumstances of the COVID-19 pandemic, and with the health and safety of its shareholders and employees a priority, Pharming will provide the opportunity to follow its upcoming EGM via a webcast.